A phase 3 study presented at IDWeek 2026 found that the Pfizer-BioNTech LP.8.1 variant-adapted COVID-19 vaccine demonstrated a favorable short-term safety profile and robust immune responses in older adults and individuals at increased risk...
A phase 3 study presented at IDWeek 2026 found that the Pfizer-BioNTech LP.8.1 variant-adapted COVID-19 vaccine demonstrated a favorable short-term safety profile and robust immune responses in older adults and individuals at increased risk...
A study presented at IDWeek 2026 found that hospital admission testing policies for SARS-CoV-2 were associated with reduced hospital-onset COVID-19 infections across Department of Veterans Affairs (VA) facilities, particularly during periods...
A study presented at IDWeek 2026 found that hospital admission testing policies for SARS-CoV-2 were associated with reduced hospital-onset COVID-19 infections across Department of Veterans Affairs (VA) facilities, particularly during periods...
At IDWeek 2026, researchers presented a poster describing COVID-19 vaccination status and perceptions among older US adults, identifying barriers toward improving vaccine uptake.
At IDWeek 2026, researchers presented a poster describing COVID-19 vaccination status and perceptions among older US adults, identifying barriers toward improving vaccine uptake.
At IDWeek 2026, Jomi Oommen, PharmD, BCIDP, discussed the impact of remdesivir restrictions on health care utilization and mortality among hospitalized patients with COVID-19.
At IDWeek 2026, Jomi Oommen, PharmD, BCIDP, discussed the impact of remdesivir restrictions on health care utilization and mortality among hospitalized patients with COVID-19.
A survey presented at IDWeek 2026 identified drug interactions, medication adjustments, and patient reluctance as leading barriers to COVID-19 antiviral prescribing, highlighting challenges relevant to the care of high-risk older adults and...
A survey presented at IDWeek 2026 identified drug interactions, medication adjustments, and patient reluctance as leading barriers to COVID-19 antiviral prescribing, highlighting challenges relevant to the care of high-risk older adults and...
